Over 99% have a risk factor before heart attack, stroke or heart failure, large-scale study finds

More than 99% of people who went on to suffer a heart attack, stroke or heart failure already had at least one risk factor ...
The New England Journal of Medicine

Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection

Thrombolytic agents, including tenecteplase, are generally used within 4.5 hours after the onset of stroke symptoms. Information on whether tenecteplase confers benefit beyond 4.5 hours is limited. We ...
The New England Journal of Medicine

Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke

Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide (an ...
Medscape

Approved Device for Stroke-Related Dysphagia Finally Enters into an RCT

ABU DHABI, UAE — A device characterized by the US Food and Drug Administration as safe for the treatment of dysphagia following acute stroke is finally being tested for efficacy in a randomized ...
Cochrane

What are the benefits and harms of remote ischaemic conditioning (briefly restricting then restoring blood flow) for preventing and treating stroke?

Remote ischaemic conditioning (RIC) involves briefly and repeatedly restricting and then restoring blood flow in a limb (an arm or leg) with a blood pressure cuff. The goal is to "condition" the limb ...